DNA Discovery Offers Hope in Cancer Treatment

 DNA Discovery Offers Hope in Cancer Treatment
Published 3 weeks ago on Jan 29, 2024

Breakthrough Discovery Unveils New Hope in Cancer Treatment: Targeting Mitochondrial DNA.

Certain types of cancers are treated with immunotherapy – drugs which harness the body's natural defences to attack cancer cells – but with varying degrees of success

In a significant stride forward in the fight against cancer, scientists have identified a groundbreaking breakthrough linking DNA to treatment efficacy, offering newfound hope to cancer patients worldwide. This pioneering discovery unveils a 'vital weak spot' within tumours, paving the way for more effective treatments and personalized therapeutic approaches.

Immunotherapy, a revolutionary treatment modality harnessing the body's immune system to combat cancer cells, has shown promise in certain types of cancers. However, its effectiveness varies among patients, posing a challenge in optimizing treatment outcomes.

Now, researchers have uncovered a pivotal strategy to enhance the efficacy of immunotherapy, centered around the 'energy factories' within tumours known as mitochondria. These specialized compartments play a crucial role in generating energy for every living cell.

Through innovative DNA manipulation techniques, scientists have demonstrated that 'rewiring' the DNA of mitochondria can significantly augment the responsiveness of tumours to immunotherapy drugs. Their findings indicate that tumors with high levels of mitochondrial DNA mutations are up to two and a half times more likely to respond favorably to treatment with drugs like nivolumab, a commonly used immunotherapy agent targeting various cancers including melanoma, lung cancer, liver cancer, and bowel cancer.

Dr. Payam Gammage, co-lead author and Group Leader at the Cancer Research UK (CRUK) Scotland Institute and the University of Glasgow, underscores the transformative potential of this discovery. He emphasizes that understanding the role of mitochondrial DNA mutations opens new avenues for predicting patient responses to immunotherapy and developing targeted therapeutic interventions.

The technology underlying this breakthrough has been swiftly patented by Cancer Research Horizons, CRUK's innovation arm, signaling a concerted effort to translate laboratory findings into tangible clinical applications. This strategic move aims to expedite the development of innovative treatments that disrupt cancer's energy sources, impeding its proliferation and progression.

Dr. Iain Foulkes, Executive Director of Research and Innovation at CRUK and CEO of Cancer Research Horizons, lauds the discovery as a pivotal milestone in cancer research. He affirms that targeting mitochondrial DNA mutations represents a fundamental vulnerability in cancer cells, offering boundless opportunities for therapeutic innovation and advancement.

Echoing this sentiment, Dr. Ed Reznik from the Memorial Sloan Kettering Cancer Center emphasizes the transformative potential of rewiring tumor energy sources to thwart cancer progression. He underscores the vast implications of this research, envisioning a future where cancer can be effectively intercepted and overcome through innovative therapeutic strategies.

Published in the prestigious journal Nature Cancer, these findings herald a new era in cancer treatment, characterized by personalized approaches that leverage the intricate interplay between DNA, immunotherapy, and tumor biology. As the scientific community continues to unravel the complexities of cancer, such breakthroughs offer renewed optimism and resilience in the quest to conquer this formidable disease.

In summary, the discovery of a 'vital weak spot' within cancer cells underscores the transformative potential of targeting mitochondrial DNA mutations in enhancing treatment efficacy and patient outcomes. With ongoing efforts to translate these findings into clinical practice, the horizon of cancer treatment appears brighter, offering hope to countless individuals affected by this relentless disease.

What is immunotherapy?  

Immunotherapy is a type of cancer treatment that uses the immune system to fight the disease.  

It helps the immune system recognise and attack cancer cells. 

It is often used against lung, cervical, head and neck and liver cancers.  

Patients can have immunotherapy on its own or with other treatments, such as chemotherapy and radiotherapy. 

The immune system works to protect the body against infection, illness and disease. It can also protect us from the cancer cells developing in the body. 

There are different types of immunotherapy as cancer treatments do not always fit easily into a certain category of treatment. 

Cancer Horoscope 2024

You will be blessed with incredible success in business, as per 2024 Cancer career predictions, along with the ability to fight obstacles. New projects and new deals will also get you recognition in foreign companies. If employed, Jupiter will assist you in getting new job opportunities and, also, a promotion after May.

This is an especially good year if you work in the government sector. Also, if you are in politics, you can expect a new position.

Saturn can cause some disturbances in your work life in the second half of the year – for instance, there may be a change in your work schedule or health issues can affect your work – but other planets in 2024 Cancer horoscope will ensure that you have the ability to overcome these challenges with your intelligence and hard work.


  • Written news comments are in no way https://www.showbizglow.com it does not reflect the opinions and thoughts of. Comments are binding on the person who wrote them.